60 likes | 70 Vues
The Germany IVF market was valued at $398 million in 2018 and is estimated to reach $541 million by 2026, registering a CAGR of 3.9% during the analysis period.
E N D
The growth in the Germany in vitro fertilization market is due to delayed marriages and parenthood decisions, and subsidizing IVF treatments. Further, about 50% of the treatment cost by IVF paid for three cycles drives the IVF market According to a new report published by Allied Market Research, titled, "Germany In Vitro Fertilization (IVF) Market by Cycle Type and End User: Opportunity Analysis and Industry Forecast, 2019-2026", The Germany IVF market was valued at $398 million in 2018 and is estimated to reach $541 million by 2026, registering a CAGR of 3.9% during the analysis period. Get Sample Report
Absence of ability or diminished ability to conceive and bear an offspring is termed as infertility. In vitro fertilization (IVF) is a process that is employed to conceive artificially. The process includes five basic steps such as stimulation, egg retrieval, insemination and fertilization, embryo culture, and embryo transfer. The entire process is performed outside the body and once the embryo is ready, it is implanted in the uterus. In the process fertilization occurs outside the body in a laboratory medium. In vitro fertilization is most often tried when other, less expensive, or invasive fertility techniques have failed.
The major factors that boost the growth of the Germany in vitro fertilization market are subsidizing IVF treatments, delayed marriages & parenting decisions, and rise in number of infertility cases. Furthermore, as per National Health Plan (NHP), about 50% of the treatment cost by IVF paid for three cycles is anticipated to drive the growth of the IVF market in Germany. However, stringent government regulations and lack of availability in treatment cycles for IVF are the major restraints that hinder the growth of the market in Germany. Moreover, surge in adoption of IVF technique in the country is expected to provide remunerative opportunities during the forecast period.
Key Findings of the Germany In Vitro Fertilization (IVF) Market : • By cycle type, fresh IVF cycles in Germany IVF market accounted for largest share in 2018. • By end user, the fertility clinics segment accounted for three-fourths of the market share in 2018. • By end user, the clinical research institutes segment is anticipated to account for one-sixth share of the market in 2018.
The major companies profiled in this report include Heidelberg University Hospital, Klinikum Stuttgart, DRK Kliniken Berlin, and University Medical Center Freiburg.